Mackenzie Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.1M Buy
165,030
+28,047
+20% +$9.6M 0.06% 239
2026
Q1
$48.2M Sell
136,983
-5,974
-4% -$2.13M 0.06% 265
2025
Q4
$46.9M Sell
142,957
-18,821
-12% -$5.97M 0.06% 264
2025
Q3
$45.7M Sell
161,778
-7,056
-4% -$2.05M 0.06% 259
2025
Q2
$47.1M Sell
168,834
-8,095
-5% -$2.29M 0.06% 238
2025
Q1
$55.1M Buy
176,929
+9,737
+6% +$2.88M 0.08% 202
2024
Q4
$43.6M Sell
167,192
-2,646
-2% -$785K 0.06% 233
2024
Q3
$54.7M Sell
169,838
-2,596
-2% -$849K 0.08% 214
2024
Q2
$53.9M Sell
172,434
-27,798
-14% -$8.17M 0.08% 203
2024
Q1
$56.9M Buy
200,232
+522
+0.3% +$153K 0.08% 200
2023
Q4
$57.5M Buy
199,710
+1,429
+0.7% +$389K 0.09% 193
2023
Q3
$51.8M Sell
198,281
-7,461
-4% -$1.86M 0.09% 190
2023
Q2
$46.3M Buy
205,742
+77,976
+61% +$18.1M 0.07% 223
2023
Q1
$30.9M Buy
127,766
+14,527
+13% +$3.57M 0.05% 277
2022
Q4
$29.7M Buy
113,239
+2,572
+2% +$689K 0.05% 270
2022
Q3
$24.9M Sell
110,667
-2,185
-2% -$530K 0.04% 287
2022
Q2
$27.5M Sell
112,852
-1,583
-1% -$388K 0.04% 280
2022
Q1
$27.7M Buy
114,435
+240
+0.2% +$55.1K 0.04% 297
2021
Q4
$25.7M Sell
114,195
-27,631
-19% -$5.83M 0.03% 320
2021
Q3
$30.2M Buy
141,826
+15,477
+12% +$3.56M 0.04% 289
2021
Q2
$30.8M Sell
126,349
-62,258
-33% -$15.3M 0.04% 275
2021
Q1
$46.9M Sell
188,607
-320,560
-63% -$76.5M 0.07% 211
2020
Q4
$117M Buy
509,167
+9,008
+2% +$2.08M 0.25% 116
2020
Q3
$127M Buy
500,159
+71,991
+17% +$17.8M 0.32% 100
2020
Q2
$101M Buy
428,168
+329,135
+332% +$75.1M 0.27% 112
2020
Q1
$20.1M Buy
99,033
+8,840
+10% +$1.93M 0.06% 214
2019
Q4
$21.7M Buy
90,193
+5,937
+7% +$1.31M 0.05% 238
2019
Q3
$16.3M Sell
84,256
-568
-0.7% -$109K 0.04% 267
2019
Q2
$15.6M Sell
84,824
-17,635
-17% -$3.16M 0.04% 261
2019
Q1
$19.5M Sell
102,459
-4,928
-5% -$941K 0.05% 274
2018
Q4
$20.9M Buy
107,387
+67,472
+169% +$13.2M 0.06% 241
2018
Q3
$8.27M Sell
39,915
-11,683
-23% -$2.3M 0.02% 379
2018
Q2
$9.52M Sell
51,598
-36,525
-41% -$6.46M 0.02% 339
2018
Q1
$15M Sell
88,123
-31,903
-27% -$5.86M 0.04% 271
2017
Q4
$20.9M Buy
120,026
+49,411
+70% +$8.74M 0.05% 254
2017
Q3
$13.2M Sell
70,615
-35,948
-34% -$6.37M 0.07% 231
2017
Q2
$18.4M Buy
106,563
+155
+0.1% +$25.2K 0.1% 188
2017
Q1
$17.5M Buy
106,408
+17,123
+19% +$2.85M 0.1% 194
2016
Q4
$13.1M Buy
89,285
+87,081
+3,951% +$13.1M 0.08% 205
2016
Q3
$368K Sell
2,204
-45,498
-95% -$7.69M ﹤0.01% 537
2016
Q2
$7.26M Sell
47,702
-3,300
-6% -$513K 0.04% 284
2016
Q1
$7.65M Buy
51,002
+2,463
+5% +$366K 0.07% 226
2015
Q4
$7.88M Buy
48,539
+6,081
+14% +$956K 0.05% 272
2015
Q3
$5.87M Buy
42,458
+12,770
+43% +$2.01M 0.04% 283
2015
Q2
$4.56M Sell
29,688
-1,235
-4% -$198K 0.02% 316
2015
Q1
$4.94M Sell
30,923
-2,573
-8% -$405K 0.03% 322
2014
Q4
$5.34M Buy
33,496
+918
+3% +$143K 0.03% 316
2014
Q3
$4.58M Sell
32,578
-29,056
-47% -$3.79M 0.02% 320
2014
Q2
$7.3M Sell
61,634
-8,851
-13% -$1.02M 0.03% 291
2014
Q1
$8.69M Buy
70,485
+10,021
+17% +$1.22M 0.04% 270
2013
Q4
$6.9M Sell
60,464
-35
-0.1% -$3.98K 0.03% 279
2013
Q3
$6.77M Sell
60,499
-11,449
-16% -$1.24M 0.03% 272
2013
Q2
$7.1M Buy
+71,948
New +$7.47M 0.03% 287

Other funds holding AMGN

Mackenzie Financial's AMGN Position: Q2 2026 in Review

Mackenzie Financial increased its Amgen (AMGN) stake by 20% in Q2 2026, buying an estimated $9.6M and bringing the position to 165,030 shares worth $56.1M. The position accounts for 0.06% of the portfolio, ranked #239.

Mackenzie Financial first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $127M in Q3 2020. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mackenzie Financial held 165,030 shares of Amgen worth $56.1M as of Q2 2026.
  • Mackenzie Financial bought 28,047 Amgen shares in Q2 2026, an estimated $9.6M.
  • Amgen made up 0.06% of Mackenzie Financial's portfolio in Q2 2026, its #239 holding.
  • Mackenzie Financial first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Mackenzie Financial's Amgen position peaked at $127M in Q3 2020.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.